In vivo PEG modification of vascular surfaces for targeted delivery

Journal of Vascular Surgery

Volumn 55, Issue 4, 2012, Pages 1087-1095

  Deglau, Timothy E ^a,b   Maul, Timothy M ^a,b,c   Villanueva, Flordeliza S ^b,c   Wagner, William R ^a,b,c  

^a University of Pittsburgh   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; MACROGOL; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL MODIFICATION; ARTERY INJURY; ARTICLE; BALLOON CATHETER; BLADDER CATHETERIZATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FEMALE; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SURFACE PROPERTY; THROMBOSIS;

ANIMALS; CATHETERIZATION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; MICROSCOPY, FLUORESCENCE; MICROSPHERES; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES; THROMBOSIS; VASCULAR SURGICAL PROCEDURES; WOUND HEALING;

EID: 84859158439     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.09.081     Document Type: Article

References (43)

1. I.D. Conde, N.S. Kleiman Arterial thrombosis for the interventional cardiologist: from adhesion molecules and coagulation factors to clinical therapeutics Catheter Cardiovasc Interv 60 2003 236 246
2. S.M. Garas, P. Huber, N.A. Scott Overview of therapies for prevention of restenosis after coronary interventions Pharmacol Ther 92 2001 165 178
3. F.G. Welt, C. Rogers Inflammation and restenosis in the stent era Arterioscler Thromb Vasc Biol 22 2002 1769 1776
4. M.D. Savage, G. Mattson, S. Desai, G.W. Nielander, S. Morgensen, E.J. Conklin Avidin-biotin Chemistry: A Handbook 2nd ed. 1994 Pierce Chemical Company Rockford
5. M.J. Roberts, M.D. Bentley, J.M. Harris Chemistry for peptide and protein pegylation Adv Drug Deliv Rev 54 2002 459 476
6. J.E. Burchenal, C.R. Deible, T.E. Deglau, A.J. Russell, E.J. Beckman, W.R. Wagner Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries J Thromb Thrombolysis 13 2002 27 33
7. C.R. Deible, E.J. Beckman, A.J. Russell, W.R. Wagner Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol J Biomed Mater Res 41 1998 251 256
8. P. Huhtinen, T. Soukka, T. Lvgren, H. Hrm Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology J Immunol Methods 294 2004 111 122
9. K. Hoya, L.R. Guterman, L. Miskolczi, L.N. Hopkins A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding Drug Deliv 8 2001 215 222
10. J. Zou, Y. Huang, K. Cao, G. Yang, H. Yin, J. Len Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model Life Sci 68 2000 153 163
11. G.W. Barone, P.C. Farley, J.M. Conerly, T.L. Flanagan, I.L. Kron Morphological and functional techniques for assessing endothelial integrity: the use of Evans blue dye, silver stains, and endothelial derived relaxing factor J Cardiovasc Surg 4 1989 140 148
12. T.E. Deglau, J.D. Johnson, F.S. Villanueva, W.R. Wagner Targeting microspheres and cells to polyethylene glycol-modified biological surfaces J Biomed Mater Res A 81 2007 578 585
13. C.R. Deible, P. Petrosko, P.C. Johnson, E.J. Beckman, A.J. Russell, W.R. Wagner Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol Biomaterials 19 1998 1885 1893
14. H. Xu, J.L. Kaar, A.J. Russell, W.R. Wagner Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion Biomaterials 27 2006 3125 3135
15. J. Hoffmann, J. Groll, J. Heuts, H. Rong, D. Klee, G. Ziemer Blood cell and plasma protein repellent properties of star-PEG-modified surfaces J Biomater Sci Polym Ed 17 2006 985 996
16. B. Thierry, F.M. Winnik, Y. Merhi, M. Tabrizian Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels J Am Chem Soc 125 2003 7494 7495
17. D.H. Geho, W.I. Smith Jr, L.A. Liotta, D.D. Roberts Fibronectin-based masking molecule blocks platelet adhesion Bioconjug Chem 14 2003 703 706
18. J.L. West, J.A. Hubbell Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing Proc Natl Acad Sci U S A 93 1996 13188 13193
19. J.L. Hill-West, S.M. Chowdhury, M.J. Slepian, J.A. Hubbell Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers Proc Natl Acad Sci U S A 91 1994 5967 5971
20. T.M. Maul, D.D. Dudgeon, M.T. Beste, D.A. Hammer, J.S. Lazo, F.S. Villanueva Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength Biotechnol Bioeng 107 2010 854 864
21. J.L. Swift, R. Heuff, D.T. Cramb A two-photon excitation fluorescence cross-correlation assay for a model ligand-receptor binding system using quantum dots Biophys J 90 2006 1396 1410
22. W.R. Gombotz, G.H. Wang, T.A. Horbett, A.S. Hoffman Protein adsorption to poly(ethylene oxide) surfaces J Biomed Mater Res 25 1991 1547 1562
23. D.A. Tulis, K.S. Bohl Masters, E.A. Lipke, R.L. Schiesser, A.J. Evans, K.J. Peyton YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function Biochem Biophys Res Commun 291 2002 1014 1021
24. K.S. Bohl, J.L. West Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation Biomaterials 21 2000 2273 2278
25. H. Alfke, H.J. Wagner, C. Calmer, K.J. Klose Local intravascular drug delivery: in vitro comparison of three catheter systems Cardiovasc Interv Radiol 21 1998 50 56
26. X. Du, Y. Yang, C. Le Visage, H.H. Chen, R. DeJong, B. Qiu In vivo US monitoring of catheter-based vascular delivery of gene microspheres in pigs: feasibility Radiology 228 2003 555 559
27. U. Westedt, M. Kalinowski, M. Wittmar, T. Merdan, F. Unger, J. Fuchs Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment J Control Release 119 2007 41 51
28. T. Kuji, T. Masaki, K. Goteti, L. Li, S. Zhuplatov, C.M. Terry Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis Kidney Int 69 2006 2179 2185
29. A.C. Thomas, J.H. Campbell Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis Atherosclerosis 176 2004 73 81
30. Y.H. Yun, D.J. Goetz, P. Yellen, W. Chen Hyaluronan microspheres for sustained gene delivery and site-specific targeting Biomaterials 25 2004 147 157
31. H.S. Sakhalkar, M.K. Dalal, A.K. Salem, R. Ansari, J. Fu, M.F. Kiani Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo Proc Natl Acad Sci U S A 100 2003 15895 15900
32. J.M. Hodgson, R.K. Bottner, L.W. Klein, H.T. Walpole Jr, D.J. Cohen, D.E. Cutlip Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues Catheter Cardiovasc Interv 62 2004 1 17
33. R. Virmani, A. Farb, G. Guagliumi, F.D. Kolodgie Drug-eluting stents: caution and concerns for long-term outcome Coron Artery Dis 15 2004 313 318
34. V. Bhatia, R. Bhatia, M. Dhindsa Drug-eluting stents: new era and new concerns Postgrad Med J 80 2004 13 18
35. D. Sibbing, K.L. Laugwitz, L. Bott-Flugel, J. Pache Very late stent thrombosis 42 months after implantation of sirolimus-eluting stent and discontinuation of antiplatelet therapy Case Report Med 2009 2009 713292
36. S. Cook, E. Ladich, G. Nakazawa, P. Eshtehardi, M. Neidhart, R. Vogel Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
37. J.J. Young Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems Rev Cardiovasc Med 8 Suppl 1 2007 S3 S10
38. M. Billinger, F. Buddeberg, J.A. Hubbell, D.L. Elbert, T. Schaffner, D. Mettler Polymer stent coating for prevention of neointimal hyperplasia J Invasive Cardiol 18 2006 423 426 Discussion:7
39. E.A. Scott, M.D. Nichols, L.H. Cordova, B.J. George, Y.S. Jun, D.L. Elbert Protein adsorption and cell adhesion on nanoscale bioactive coatings formed from poly(ethylene glycol) and albumin microgels Biomaterials 29 2008 4481 4493
40. T.M. Maul, D.D. Dudgeon, M.T. Beste, D.A. Hammer, J.S. Lazo, F.S. Villanueva Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength Biotechnol Bioeng 107 2010 854 864
41. J.B. Haun, D.A. Hammer Quantifying nanoparticle adhesion mediated by specific molecular interactions Langmuir 24 2008 8821 8832
42. A. Pierres, D. Touchard, A.-M. Benoliel, P. Bongrand Dissecting streptavidin-biotin interaction with a laminar flow chamber Biophys J 82 2002 3214 3223
43. E. Levy-Nissenbaum, A.F. Radovic-Moreno, A.Z. Wang, R. Langer, O.C. Farokhzad Nanotechnology and aptamers: applications in drug delivery Trends Biotechnol 26 2008 442 449